
REGENERON PHARMACEUTICALS (NASDAQ:REGN) - A Potential Undervalued Biotech Stock
REGENERON PHARMACEUTICALS (NASDAQ:REGN) was identified by our Decent Value stock screener as a company with strong fundamentals and an attractive valuation. The biotech firm demonstrates solid profitability and financial health while trading at a …